Billionaire investor Stanley Druckenmiller significantly ramped up his bets on artificial-intelligence-linked stocks in the second quarter, according to a regulatory filing from his Duquesne Family Office released this week. The timing is notable: the buying spree happened just before AI and semiconductor shares suffered a sharp reversal in July, when investors began questioning stretched valuations and the pace of AI infrastructure spending. Druckenmiller, who rose to fame helping engineer George Soros’s legendary bet against the British pound in 1992, is one of the most closely watched macro investors on Wall Street, so any shift in his portfolio tends to draw attention.
The filing shows Duquesne dramatically increased its Amazon stake to roughly $129 million and opened a fresh $120 million position in Alphabet, bringing Google’s parent back into the portfolio after Druckenmiller exited it entirely in the first quarter. He also leaned harder into chipmakers, boosting his Taiwan Semiconductor Manufacturing stake by 19% to $282 million and his STMicroelectronics position by nearly 19% to $232 million — making the two chip names his second- and third-largest common stock holdings. Smaller new positions in Advanced Micro Devices and Palo Alto Networks rounded out the AI-adjacent buying. Genetic testing company Natera remained his single largest holding, worth more than $800 million at quarter’s end, underscoring that healthcare diagnostics still anchor the portfolio even as AI exposure grew.
For retail investors, the lesson isn’t to blindly copy a hedge fund’s 13F. Filings only capture positions as of June 30, so there’s no way to know whether Druckenmiller held through July’s rout or trimmed exposure once cracks appeared. What the filing does confirm is that even one of Wall Street’s most respected macro investors was leaning hard into mega-cap AI and semiconductor names right before volatility hit — a reminder that conviction and timing are two very different things. Investors who already own Amazon, Alphabet, or TSM shouldn’t panic-sell on one rough month, but anyone considering fresh exposure should size positions carefully, watch valuation multiples closely, and avoid chasing headlines based on a 45-day-old snapshot of someone else’s portfolio.
